Avalo Therapeutics, Inc.
$927.80M- Market cap
- $1.03B
- Debt
- +-$5.17M
- Cash
- −$98.34M
Capital structure 101% equity / -1% debt · EV / Revenue 15725.35x
Quick read
Fair value engine
Each company valued on the other's multiple, then compared with the market price.
AVTX · current priceP/S 17479.74x
$19.23Latest market snapshot
Implied fair value · at AES's multiple
$0.00100.0% below market
0.00 AVTX revenue / share×0.86x AES P/S=$0.00
Market $19.23Implied $0.00
AES · current priceP/S 0.86x
$14.79Latest market snapshot
Implied fair value · at AVTX's multiple
$299,716.972,026,383.9% above market
17.15 AES revenue / share×17479.74x AVTX P/S=$299,716.97
Market $14.79Implied $299,716.97